Sort
23,748 grants matching “melanoma”
Epigenetic regulation of exhausted CD8 T cells via the miR-29a-TET2 axis
$425,216Erietta Stelekati · University Of Miami School Of Medicine · R01 · FY2024 · AI
Identifying Therapeutic Targets for Stage III Melanoma
$425,106Anand K Ganesan · University Of California-Irvine · R01 · FY2020 · CA
Training Program in Cancer Immunobiology
$425,099Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2008 · CA
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
$424,991Mei Kong · University Of California-Irvine · R01 · FY2025 · CA
ATF2 in melanoma development and progression
$424,975Burnham Institute For Medical Research · R01 · FY2005 · CA
PEG-like Multimodal Nanoprobes for Imaging Enhanced Permeability Retention
$424,882Lee Josephson · Massachusetts General Hospital · R01 · FY2014 · EB
Biostatistics Facility
$424,881Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Biostatistics Facility
$424,881Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
PHIP as a Biomarker of Triple-Negative Melanoma
$424,835Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2014 · CA
PHIP as a Biomarker of Triple-Negative Melanoma
$424,835Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2016 · CA
PHIP as a Biomarker of Triple-Negative Melanoma
$424,835Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2015 · CA
PHIP as a Biomarker of Triple-Negative Melanoma
$424,835Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2017 · CA
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
$424,806Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2010 · CA
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
$424,715Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2020 · CA
A redox-mediated mechanism of UVB-induced metabolic switch in skin carcinogenesis
$424,685Daret K St Clair · University Of Kentucky · R01 · FY2018 · CA
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
$424,639Maurizio Pellecchia · University Of California Riverside · R01 · FY2022 · CA
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
$424,639Maurizio Pellecchia · University Of California Riverside · R01 · FY2023 · CA
Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver
$424,633Michelle Hughes · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$424,612Lei Zheng · Johns Hopkins University · R01 · FY2015 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$424,612Lei Zheng · Johns Hopkins University · R01 · FY2016 · CA
Prostate Pre-Clinical
$424,583Fred W Hetzel · University Of Colorado Denver · P01 · FY2007 · CA
Structural Biology of GTPase Activating Proteins
$424,276R Byrd · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mechanisms of PAK1 activation, signaling and tumor resistance
$424,266Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Training Program in Cancer Immunobiology
$424,244Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2013 · CA
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$424,200Todd W Ridky · University Of Pennsylvania · R01 · FY2022 · CA